Etiket: Theratechnologies
Risk of supply problem | Theratechnologies issues warning, shares lose 15%
Shares of Montreal biopharmaceutical company Theratechnologies fell 15% on Wednesday after announcing a risk of a temporary interruption in the supply of its injectable drug tesamorelin (Egrifta). Published yesterday at…
FDA Non-Approval Letter | Theratechnologies receives bad news, the stock plunges
The action of Montreal biopharmaceutical company Theratechnologies lost 15% of its value on Wednesday after receiving bad news from American health authorities. Published yesterday at 4:35 p.m. The company says…
Investissement Québec to the rescue of Theratechnologies
Investissement Québec is releasing US 12.5 million to become the largest shareholder of Theratechnologies, an investment which gives the state-owned company a 19.9% stake in the Montreal biopharmaceutical company. Posted…
Theratechnologies eliminates 25 positions | The Press
Montreal biopharmaceutical Theratechnologies is once again reducing the size of its research and development activities, leading to the elimination of some 25 positions. Published at 9:15 a.m. Big boss Paul…
Theratechnologies falls on the stock market | The Press
Theratechnologies shares lost 36% of their value Friday on the Toronto Stock Exchange after the Montreal biopharmaceutical company decided to review the design of its clinical trials of an agent…